高级检索
当前位置: 首页 > 详情页

Knockdown of zinc transporter ZIP5 (SLC39A5) expression significantly inhibits human esophageal cancer progression

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Inst Canc, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China [2]Hebei Med Univ, Gen Surg, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China
出处:
ISSN:

关键词: esophageal cancer ZIP5 COX2 cyclin D1 E-cadherin

摘要:
ZIPS is a central player in mammalian zinc metabolism. Studies suggest that ZIP5 is differentially expressed during esophageal tumorigenesis, yet the role of ZIPS in esophageal cancer cells has not yet been clarified. Immunohistochemistry, western blotting and qRT-PCR techniques were used to detect ZIPS expression in esophageal squamous cell carcinoma (ESCC) tissues. We established a stable knockdown ZIPS cell line (KYSE170K) derived from the ESCC cell line KYSE170. We conducted MTT and CCK-8 assays to determine the role of ZIPS in cell proliferation, Transwell assays to detect migration and invasion, and flow cytometry (FCM) to detect apoptosis and cell cycle percentage using KYSE170K cells. We conducted a gene profiling study to detect the expression of genes related to tumor progression. The results demonstrated that ZIPS protein and mRNA expression was highest in ESCC, intermediate in para-carcinoma and lowest in normal tissue. ZIPS knockdown decreased proliferation by 28 and 38%, respectively, according to the MTT and CCK-8 assays. Migration and invasion decreased by 54 and 68%, respectively, according to the Transwell assays. COX2 expression was decreased by 68 and 75% at the mRNA and protein level, respectively, and cyclin D1 mRNA and protein expression was decreased following 62 and 60%, respectively, by knockdown of ZIPS, which upregulated the mRNA and protein expression of E-cadherin by 80 and 60%, respectively. ZIPS knockdown inhibited the proliferation, migration and invasion of ESCC and suppressed COX2, cyclin D1 and E-cadherin expression, which led to the inhibition of cell progression in ESCC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q3 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Inst Canc, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Inst Canc, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China [*1]Cancer Institute, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号